首页> 美国卫生研究院文献>MedChemComm >Novel O-methyl goniofufurone and 7-epi-goniofufurone derivatives: synthesis in vitro cytotoxicity and SAR analysis
【2h】

Novel O-methyl goniofufurone and 7-epi-goniofufurone derivatives: synthesis in vitro cytotoxicity and SAR analysis

机译:新型O-甲基gonfufufurone和7-epi-goniofufurone衍生物:合成体外细胞毒性和SAR分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Novel goniofufurone (>1) and 7-epi-goniofufurone (>2) derivatives bearing a methoxy group at the C-5 and/or C-7 positions were prepared and their in vitro antitumour activity against some human tumour cell lines was evaluated. Some of the analogues displayed powerful antiproliferative effects against the studied tumour cells, but almost all of them were non-cytotoxic toward the normal cells (MRC-5). A SAR study reveals that the introduction of a methoxy group at the C-7 position may increase the antiproliferative effects of the analogues. The most active compounds are 7-O-methyl derivatives of goniofufurone (>3) and 7-epi-(+)-goniofufurone (>6), which exhibited 1177- and 451-fold higher potencies than the leads >1 and >2 toward the MDA-MB 231 cell line. At the same time, compound >3 is almost 1.5-fold more active than the commercial drug doxorubicin (DOX) against the same cell line. Flow cytometry data confirmed that the cytotoxic effects of these analogues are mediated by apoptosis, additionally revealing that these molecules induced changes in the K562 cell cycle distribution.
机译:制备了在C-5和/或C-7位置带有甲氧基的新型goniofufurone(> 1 )和7-epi-goniofufurone(> 2 )衍生物,评价了对某些人肿瘤细胞系的体外抗肿瘤活性。一些类似物对所研究的肿瘤细胞显示出强大的抗增殖作用,但几乎所有类似物均对正常细胞(MRC-5)无细胞毒性。 SAR研究表明,在C-7位置引入甲氧基可能会增加类似物的抗增殖作用。活性最高的化合物是goniofufurone(> 3 )和7-epi-(+)-goniofufurone(> 6 )的7-O-甲基衍生物,分别显示1177-和451指向MDA-MB 231细胞系的导线> 1 和> 2 的效能是其两倍的。同时,化合物> 3 对同一细胞系的活性比市售药物阿霉素(DOX)强1.5倍。流式细胞仪数据证实,这些类似物的细胞毒性作用是由细胞凋亡介导的,另外揭示了这些分子诱导了K562细胞周期分布的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号